Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Edwards Lifesciences Sees FY24 Adj. EPS $2.70-$2.80 Vs $2.76 Est.; Revenue $6.3B-$6.6B Vs $6.516B Est.

Author: Benzinga Newsdesk | April 25, 2024 04:20pm

Posted In: EW